Optimal Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Optimal Asset Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$755K	Buy	4,161 +11	+0.3%	+$2.15K	0.09%	268
2021 Q2	$837K	Hold	4,150	–	–	0.1%	270
2021 Q1	$892K	Buy	4,150 +2,200	+113%	+$483K	0.12%	250
2020 Q4	$461K	Sell	1,950 -1,906	-49%	-$437K	0.07%	351
2020 Q3	$1.05M	Buy	3,856 +2,624	+213%	+$724K	0.15%	215
2020 Q2	$358K	Sell	1,232 -5,795	-82%	-$1.57M	0.06%	358
2020 Q1	$1.67K	Buy	7,027 +1,322	+23%	+$303K	0.16%	216
2019 Q4	$1.25M	Buy	+5,705	New	+$1.15M	0.19%	202

Other funds holding VRTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Optimal Asset Management's VRTX Position: Q3 2021 in Review

Optimal Asset Management increased its Vertex Pharmaceuticals (VRTX) stake by 0.27% in Q3 2021, buying an estimated $2.15K and bringing the position to 4,161 shares worth $755K. The position accounts for 0.09% of the portfolio, ranked #268.

Optimal Asset Management first reported a position in VRTX in Q4 2019 and has held it in 8 quarters since. The position peaked at $1.25M in Q4 2019. 933 funds tracked by Wall St. Rank hold VRTX as of Q3 2021.

Optimal Asset Management held 4,161 shares of Vertex Pharmaceuticals worth $755K as of Q3 2021.
Optimal Asset Management bought 11 Vertex Pharmaceuticals shares in Q3 2021, an estimated $2.15K.
Vertex Pharmaceuticals made up 0.09% of Optimal Asset Management's portfolio in Q3 2021, its #268 holding.
Optimal Asset Management first reported a position in Vertex Pharmaceuticals in Q4 2019 and has held it in 8 quarters since.
Optimal Asset Management's Vertex Pharmaceuticals position peaked at $1.25M in Q4 2019.
933 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2021.

Based on Optimal Asset Management's 13F filing for Q3 2021, filed 15 Nov 2021.